Top 28 Remix Therapeutics investors
The most complete profiles first. Showing 28 of 28.
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Jernej GodecVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Kevin BittermanVerified
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 70 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Alex HardingVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Jason RhodesVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Kristina Burow
Venture Capital, Private Equity Firm, Investor · United States
SeedPre-SeedHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: Lycera, Kilimanjaro Energy, Orbital Therapeutics, Vividion Therapeutics and 6 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Jean
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Steven Robinette
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Magenta Therapeutics, Remix Therapeutics, Vigil Neuroscience, Quartet Medicine and 62 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Remix Therapeutics investors are on Angel Roster?
Angel Roster lists 28 Remix Therapeutics investors. 16 of them (57%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (28), Private Equity Firms (15) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Remix Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (11), Series B (8) and Pre-Seed (1).
Where are Remix Therapeutics investors based?
Most are based in the United States (26) and the United Kingdom (2).
Which companies have Remix Therapeutics investors backed?
The most-backed portfolio companies among them are LifeMine Therapeutics (16), Maze Therapeutics (16), Bit Bio (16), Insitro (16) and Mindstrong (16).
How do I contact Remix Therapeutics investors?
Create a free Angel Roster account to search and filter all 28, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.